company background image
0RQO logo

Bonesupport Holding LSE:0RQO Stock Report

Last Price

SEK 382.00

Market Cap

SEK 25.1b

7D

4.9%

1Y

109.9%

Updated

23 Dec, 2024

Data

Company Financials +

Bonesupport Holding AB (publ)

LSE:0RQO Stock Report

Market Cap: SEK 25.1b

0RQO Stock Overview

An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. More details

0RQO fundamental analysis
Snowflake Score
Valuation1/6
Future Growth6/6
Past Performance1/6
Financial Health6/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Bonesupport Holding AB (publ) Competitors

Price History & Performance

Summary of share price highs, lows and changes for Bonesupport Holding
Historical stock prices
Current Share PriceSEK 382.00
52 Week HighSEK 384.40
52 Week LowSEK 173.40
Beta0.99
1 Month Change6.05%
3 Month Change29.39%
1 Year Change109.86%
3 Year Change871.61%
5 Year Change1,173.33%
Change since IPO1,719.05%

Recent News & Updates

Recent updates

Shareholder Returns

0RQOGB BiotechsGB Market
7D4.9%-5.1%-2.2%
1Y109.9%-24.5%2.4%

Return vs Industry: 0RQO exceeded the UK Biotechs industry which returned -24.5% over the past year.

Return vs Market: 0RQO exceeded the UK Market which returned 2.4% over the past year.

Price Volatility

Is 0RQO's price volatile compared to industry and market?
0RQO volatility
0RQO Average Weekly Movement5.5%
Biotechs Industry Average Movement7.0%
Market Average Movement4.8%
10% most volatile stocks in GB Market10.5%
10% least volatile stocks in GB Market2.6%

Stable Share Price: 0RQO has not had significant price volatility in the past 3 months compared to the UK market.

Volatility Over Time: 0RQO's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1999131Emil Billbäckwww.bonesupport.com

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also offers CERAMENT Bead Tray, an adjunctive local delivery option for surgeons for targeted delivery to osseous defects and for dead space management.

Bonesupport Holding AB (publ) Fundamentals Summary

How do Bonesupport Holding's earnings and revenue compare to its market cap?
0RQO fundamental statistics
Market capSEK 25.14b
Earnings (TTM)SEK 90.58m
Revenue (TTM)SEK 814.46m

277.5x

P/E Ratio

30.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0RQO income statement (TTM)
RevenueSEK 814.46m
Cost of RevenueSEK 61.64m
Gross ProfitSEK 752.82m
Other ExpensesSEK 662.24m
EarningsSEK 90.58m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 25, 2025

Earnings per share (EPS)1.38
Gross Margin92.43%
Net Profit Margin11.12%
Debt/Equity Ratio0%

How did 0RQO perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 15:32
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bonesupport Holding AB (publ) is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Maria Vara FernándezBryan Garnier & Co
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB
Jonas PeciulisEdison Investment Research